Ratings
Negative
Marriott Vacations targets $150M–$200M run rate EBITDA benefit by 2026 as operational changes take hold
Breaking news from global financial markets
1 day ago
Read More
1 day ago
1,850
1 day ago
1,288
1 day ago
1,246
1 day ago
4,114
1 day ago
3,231
1 day ago
4,402
1 day ago
4,406
Equinor ASA: Transaksjoner i kapitalmarkedet
Regulations
1 day ago
720
1 day ago
3,865
Archer Aviation reports Q3 results
Earnings
1 day ago
4,225
1 day ago
3,591
1 day ago
3,033
1 day ago
2,367
1 day ago
532
1 day ago
2,918
1 day ago
3,871
DARZALEX FASPRO® is the first and only treatment approved by the U.S. FDA for patients with high-risk smoldering multiple myeloma
Corporate Actions
1 day ago
2,622
1 day ago
561
Trending Now
1
Elon Musk Says Optimus Robot Will Replace Jobs and Enable Universal Income
10,905
36 minutes ago
2
Energy company serving 38 states files Chapter 11 bankruptcy
14,401
36 minutes ago
3
Cheers! Beer and Liquor Stocks on Sale With High Yields to 7.25%
10,939
40 minutes ago
4
MOH FINAL DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Molina Healthcar...
1,415
48 minutes ago
5
This 29-year-old trader just became Goldman's youngest MD. Here's how he celebra...
21,214
50 minutes ago